Studies involving pediatric or neonate populations are drastically different from adult trials in terms of recruitment challenges, operational logistics, and regulatory considerations.

CTI has diverse experience in these populations in both clinical study management and regulatory consulting across a wide array of indications.

Through 20 years of involvement in pediatric research, we have built relationships with leading research centers around the globe. We are acutely aware of the unique program development and execution challenges pediatric research presents, and we can provide guidance, expertise, and efficiency to pediatric development programs for our sponsors. We attend industry meetings and are members of many pediatric societies, including the American Society of Pediatric Nephrology (ASPN), the International Pediatric Transplant Association (IPTA), and Society of Pediatric Liver Transplantation (SPLIT).

We offer our sponsors:

Some of our pediatric experience includes:

  • 5-Fluorouracil toxicity
  • Alport's syndrome
  • Adenovirus
  • Βeta-Thalassemia
  • Bronchopulmonary dysplasia
  • Cerebral adrenoleukodystrophy
  • Delayed graft function (DGF)
  • Focal segmental glomerulosclerosis (FSGS)
  • Graft versus host disease (GVHD)
  • Heparin-induced thrombocytopenia (HIT)
  • Hunter’s syndrome (mucopolysaccharidosis II)
infinity symbol


More than 30% of our active trails involve pediatric populations, giving our team significant experience in working with families as an important component of screening, enrollment, and retention.